Accuray (ARAY) Cash from Operations Growth (3y) (2013 - 2026)
Accuray (ARAY) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 0.50% |
| 10 | Accuray | 27,968.40 | -38.51 Mn | 25.29 Mn | -41.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.64% |
| Dec 31, 2025 | 3.90% |
| Sep 30, 2025 | 542.14% |
| Mar 31, 2025 | 77.59% |
| Dec 31, 2024 | -61.92% |
| Sep 30, 2024 | 5.34% |
| Mar 31, 2024 | -38.80% |
| Dec 31, 2023 | -31.31% |
| Sep 30, 2023 | -44.12% |
| Mar 31, 2023 | 36.61% |
| Dec 31, 2022 | -45.73% |
| Sep 30, 2022 | 26.03% |
| Mar 31, 2022 | 32.28% |
| Dec 31, 2021 | 63.46% |
| Sep 30, 2021 | 21.57% |
| Mar 31, 2021 | 97.66% |
| Dec 31, 2020 | 207.40% |
| Sep 30, 2020 | 39.60% |
| Jun 30, 2020 | -6.66% |
| Mar 31, 2020 | 1.01% |